ClinicalTrials.gg
RecruitingNCT06736951Updated Dec 17, 2024

Modifying the Inpatient Environment to Reduce Delirium in Older Adults

An interventional study of MMSH (Multi-Modal Sleep Hygiene) Bundle in Delirium and Sleep Hygiene, sponsored by Farhaan S. Vahidy. Recruiting at 5 sites in United States. Open to participants aged 70 Years and older. Per ClinicalTrials.gov, last updated 2024-12-17.

Sponsored by Farhaan S. Vahidy · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jun 2024, registered Sep 2024).
  • Started Jun 2024; still recruiting 2 years 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
10,890
Allocation
Randomized
Ages
70 Years and older
Sex
All
01

Study summary

The overall goal is to reduce the incidence and burden of delirium, as measured by the delirium burden index (DBI) among hospitalized older adults (≥70 years), by modifying the inpatient environment to decrease its sleep antagonism. The investigators propose to implement a multi-modal sleep hygiene (MMSH) bundle, an enhancement of a previously reported sleep-focused intervention which had 88 - 100% compliance for intervention components, and reduced ICU delirium by 50%.

Read the detailed description

The Investigators will implement the MMSH in a randomized step-wedge cluster design across 11 independent nursing units of 4 Methodist hospitals. While primarily focusing on the MMSH effectiveness, the investigators will conduct process evaluation to identify barriers and facilitators for MMSH implementation.

Specific Aim 1: Establish the comparative effectiveness of an in-hospital, MMSH towards reducing the rate of incident (hospital acquired) delirium (HAD) among older adults (age ≥ 70). The investigators will compare the rate of incident delirium between patients receiving the MMSH bundle in addition to the Standard of Care delirium screening and prevention protocol (SOC-DSPP), and those who are managed only under the SOC-DSPP. The SOC-DSPP through out all HM units includes twice daily deliruim screening with the 4AI. Outcome: The primary outcome is incident delirium (or HAD), determined by a positive 4AT, among patients who did not have delirium present on admission. The investigators hypothesize a 33% reduction in incident delirium among patients receiving the MMSH bundle.

Specific Aim 2: Establish the comparative effectiveness of an in-hospital, MMSH towards reducing delirium burden, as measured by DBI, among older adults (age ≥ 70), either with HAD or with D-POA. The investigators will compare the DBI between patients receiving the MMSH bundle in addition to the SOC-DSPP with that of those who were managed only under the SOC-DSPP. Outcome: The primary outcome is patient-level DBI [(number of positive 4AT screens)2/total number of 4AT screens)]. The DBI will be a non-zero positive fraction which is scale free because it accounts for the duration of observation by taking into consideration the total number of delirium assessments. Investigators hypothesize a 25% reduction in DBI among patients receiving the MMSH bundle.

Specific Aim 3: Evaluate the barriers and facilitators of implementing a MMSH bundle across community and academic hospitals and assess compliance with various MMSH bundle components. Outcomes: The outcomes are the reasons and factors that either promote or hinder implementation of the MMSH bundle. The investigators will also measure proportional compliance with each MMSH bundle component across the entire period implementation for all clusters (units).

Exploratory Aim: Compare sleep quality, as monitored by actigraphy, between patients receiving the MMSH bundle in addition to the SOC-DSPP with that of those who were managed under the SOC-DSPP only. Outcome: The outcomes are sleep duration, and frequency of awakenings during the hours of 10:00 pm and 5:00 am (i.e., Z-time) ,day to day variability and circadian rest-activity rhythm.

02

Conditions studied

  • Delirium
  • Sleep Hygiene
03

In context

Delirium

1,071 studies on the registry are indexed under Delirium; 239 are open to participants now.

This study's planned enrollment of 10,890 is above the median of 119 across 608 interventional studies indexed under Delirium.

Browse Delirium studies →

Lead sponsor

This is the only study on the registry with Farhaan S. Vahidy as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
70 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Non-critically ill patients (≥70 years)
  • All sexes
  • All races and ethnicities
  • Admitted to the pre-specified clinical units which are part of the study

Exclusion criteria

Exclusion criteria (applied during analysis):

  • Patients with active alcohol or substance withdrawal.
  • Patients with acute psychiatric illness
  • Patients with initial admission to intensive care unit including requirement for mechanical ventilation.
  • Patients present on a unit at the time of unit randomization
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
10,890 participants (estimated)

Study arms

  • Experimental
    MMSH (Multi-Modal Sleep Hygiene) Bundle

    We will implement an MMSH bundle, enhancing a previously reported sleep focused intervention, in order to increase quality/quantity of sleep during Z-time (i.e., 10pm to 5am) in our intervention units, subsequently mitigating the burden of delirium in hospitalized older adults. Our proposed intervention domains perfectly align with the expressed patient suggestions to improve patient experience. Sleep disruption issues were raised at similar rates across the age span suggesting our MMSH will positively impact patients of all ages, including those with lower risk of delirium. The intervention components are outlined below and a comparison to the current standard of care and the components that are relevant to the fidelity aspects of the study are highlighted in the table. The main focus of the sleep interventions will focus on Noise, Light, Staff-Patient Interactions, Daytime Activity and Medications.

    Other: MMSH (Multi-Modal Sleep Hygiene) Bundle

  • No intervention
    Standard of Care

    This study arm reflects patients receiving standard of care treatment without any modification of in-hospital sleep environment

Interventions

  • OtherMMSH (Multi-Modal Sleep Hygiene) Bundle

    Focus on Noise Reduce Noise Perception, Reduce Hallway Noise, Reduce Noise in Rooms Focus on Light Reduce Lights at Night, Increase Light in Day, Reduce Light Perception Focus on Staff-Patient Interactions Delirium Screening, Avoid Care Procedures at Night, Z-time Plan \& Prep Focus on Daytime Activity Increased Mobility, Increase Patient Engagement Focus on Medications Pain Management, Medication Monitoring, Continue pharmacy protocols, Timing of Medications/Monitoring Labs

06

What researchers measure

Primary outcomes

  1. Incidence (cumulative or proportion) of hospital acquired delirium (HAD) among patients who did not have delirium present on admission (D-POA)

    Proportion of patients who develop HAD among those who did not have D-POA. D-POA is defined as 4AT positivity (at least one) during the first 48 hours of hospital admission. HAD is defined as 4AT positivity (at least one) after 48 hours of 4AT negatives.

    Time frame: From the date of admission to the date of discharge or death, whichever comes first, outcome will be assessed at every 12 hours (twice in a 24 hour time period), up to 5 years

  2. Delirium Burden Index (DBI) among patients with either delirium present on admission or those who develop HAD

    Proportion of positive 4AT assessments (squared) among all 4AT assessments. Patient level metric of delirium burden. Scale free, non-zero number. \[(#4AT+)2 / #Total 4AT\]

    Time frame: From the date of admission to the date of discharge or death, whichever comes first, outcome will be assessed at every 12 hours (twice in a 24 hour time period), up to 5 years

  3. Adherence to MMSH bundle components: Nighttime and Daytime

    Reported as frequency and proportion of patients among whom full implementation was possible. Frequency and proportion of adherence with individual bundle components.

    Time frame: Starting from the date of randomization till the date of termination of the study assessments will be made twice weekly for each unit, up to 5 years

  4. Factors facilitating or impeding implementation of MMSH bundle

    Qualitative / thematic analysis of semi-structured focus groups with unit staff and PFAC stakeholders

    Time frame: From the date of randomization assessments made up to 5 years

Secondary outcomes

  1. Resolution of delirium present on admission (D-POA)

    Proportion of D-POA patients who resolve delirium. Defined as no positive 4AT screens following 48-hours of hospitalization among those who were positive during first 48 hours

    Time frame: From the date of admission to the date of discharge or death, whichever comes first, outcome will be assessed at every 12 hours (twice in a 24 hour time period), up to 5 years

  2. Delirium Assessment Positivity Rate

    Patient level indicator for the proportion of positive 4AT screen to the total number of 4AT screens for both D-POA and HAD patients

    Time frame: From the date of admission to the date of discharge or death, whichever comes first, outcome will be assessed at every 12 hours (twice in a 24 hour time period), up to 5 years

  3. Length of Hospital Stay (days)

    Median (interquartile range) for number of days of hospitalization, compared between intervention and SOC patients

    Time frame: From the date of admission to the date of discharge or death, whichever comes first, up to 5 years

  4. Delirium free days

    Among patients with either incident delirium or delirium present on admission, the number of days (24 hours periods) which were free of delirium (all negative 4AT screens).

    Time frame: From the date of admission to the date of discharge or death, whichever comes first, outcome will be assessed at every 12 hours (twice in a 24 hour time period), up to 5 years

  5. In hospital mortality

    Proportion of patients experiencing in hospital mortality for intervention vs the SOC groups

    Time frame: Date of admission to the date of discharge or the date of death, which ever comes first, up to 5 years

  6. Hospital discharge disposition

    Favorable discharge disposition (home or rehab) vs. unfavorable disposition (SNF, LTAC, Nursing Home)

    Time frame: Date of admission to the date of discharge (for patients discharged alive), up to 5 years

  7. In Hospital complications

    Pre-defined set of in-hospital complications (pneumonia, sepsis, UTI, DVT) will be tracked.

    Time frame: Date of admission to the date of discharge or death, whichever comes first, up to 5 years

  8. Need for higher level of care

    Need for higher acuity care

    Time frame: Date of admission to the date of discharge or death, which ever comes first, up to 5 years

  9. Duration of daytime sleeping via actigraphy (non Z-time sleeping)

    Analysis of actigraphy data. Non - Z time sleep duration

    Time frame: Baseline to Year 5

  10. Patient Experience

    HCAHPS scores in patients aged 65 and older by unit preintervention versus post intervention. The question used will be: "During this hospital stay, how often was the area around your room quiet at night?"

    Time frame: Baseline to Year 5

  11. Mobilization/Daytime Activity

    Mobility Dashboard data of Percentage of Patient Days per unit with Any Activity Documented in patients aged 70 or greater on the intervention unit

    Time frame: Date of admission to the date of discharge or death (which ever comes first), up to 5 years

  12. Sleep Quality for Actigraphy Patients

    Daily sleep quality survey and post-discharge sleep quality survey

    Time frame: From the date of enrollment to the date of discharge or death, which ever comes first, assessed daily (for the daily survey), and assessed once post-discharge (for the post-discharge survey), up to 5 years

  13. Sleep quality for all enrolled patients

    Alternate day sleep quality survey for all enrolled patients (excluding actigraphy patients)

    Time frame: Date of admission to the date of discharge, or death, whichever comes first, assessed every other day, up to 5 years.

  14. Incidence rate of hospital acquired delirium (HAD) among patients who did not have delirium present on admission (DPOA)

    Number of new cases of delirium (among those who were non-D-POA) per person-time.

    Time frame: From the date of admission to the date of discharge or death, whichever comes first, outcome will be assessed at every 12 hours (twice in a 24 hour time period), up to 5 years

Other outcomes

  1. Duration of nighttime (10:00 pm to 5:00 am - 'Z-time') sleep time

    Analysis of actigraphy data.

    Time frame: Baseline to Year 5

  2. Frequency of nocturnal (10:00 pm to 5:00 am - 'Z-time') awakenings

    Analysis of actigraphy data.

    Time frame: Baseline to Year 5

07

Study locations

5 of 5 sites recruiting
  • Houston Methodist Baytown Hospital
    Baytown, Texas 77521, United States
    Recruiting
  • Houston Methodist Hospital
    Houston, Texas 77030, United States
    Recruiting
  • Houston Methodist Research Institute
    Houston, Texas 77030, United States
    Recruiting
  • Houston Methodist West Hospital
    Houston, Texas 77094, United States
    Recruiting
  • Houston Methodist Sugarland Hospital
    Sugarland, Texas 77479, United States
    Recruiting
08

References and documents

Publications

  • Patel J, Baldwin J, Bunting P, Laha S. The effect of a multicomponent multidisciplinary bundle of interventions on sleep and delirium in medical and surgical intensive care patients. Anaesthesia. 2014 Jun;69(6):540-9. doi: 10.1111/anae.12638. PubMed 24813132 ↗

Individual participant data

Plan to share: Undecided — The plan to share IPD is undecided.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 17, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06736951
Lead sponsor
Farhaan S. Vahidy
Collaborators
Patient-Centered Outcomes Research Institute
Responsible party
Farhaan S. Vahidy (Adjunct Professor of Neurosurgery, The Methodist Hospital Research Institute) — Sponsor-investigator
First posted
Dec 17, 2024
Start date
Jun 1, 2024
Primary completion
Mar 31, 2029 (estimated)
Completion
Mar 31, 2029 (estimated)
Last update
Dec 17, 2024

Study contacts

Rejani Nair, BSN
Contact
rrnair@houstonmethodist.org
346-356-1496
Farhaan Vahidy, PhD
principal investigator · The Methodist Hospital Research Institute

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion